Mylan N.V. Sees Unusually Large Options Volume (NASDAQ:MYL)

Mylan N.V. (NASDAQ:MYL) was the target of some unusual options trading on Monday. Stock traders purchased 9,410 call options on the company. This represents an increase of approximately 250% compared to the average daily volume of 2,688 call options.

In other Mylan N.V. news, insider Anthony Mauro sold 10,000 shares of Mylan N.V. stock in a transaction on Friday, June 9th. The stock was sold at an average price of $40.00, for a total transaction of $400,000.00. Following the sale, the insider now owns 140,653 shares of the company’s stock, valued at approximately $5,626,120. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Rajiv Malik sold 25,000 shares of Mylan N.V. stock in a transaction on Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the sale, the president now directly owns 799,855 shares in the company, valued at approximately $31,994,200. The disclosure for this sale can be found here. Insiders own 0.69% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Veritable L.P. increased its stake in shares of Mylan N.V. by 34.7% in the second quarter. Veritable L.P. now owns 9,119 shares of the company’s stock valued at $354,000 after buying an additional 2,347 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Mylan N.V. by 20.8% in the second quarter. Dimensional Fund Advisors LP now owns 2,940,967 shares of the company’s stock valued at $114,171,000 after buying an additional 507,098 shares during the last quarter. Senzar Asset Management LLC increased its stake in shares of Mylan N.V. by 318.6% in the second quarter. Senzar Asset Management LLC now owns 907,100 shares of the company’s stock valued at $35,214,000 after buying an additional 690,400 shares during the last quarter. Baker Avenue Asset Management LP increased its stake in shares of Mylan N.V. by 2.5% in the second quarter. Baker Avenue Asset Management LP now owns 65,850 shares of the company’s stock valued at $2,556,000 after buying an additional 1,612 shares during the last quarter. Finally, Parametric Portfolio Associates LLC increased its stake in shares of Mylan N.V. by 87.3% in the second quarter. Parametric Portfolio Associates LLC now owns 835,779 shares of the company’s stock valued at $32,445,000 after buying an additional 389,511 shares during the last quarter. 70.19% of the stock is currently owned by institutional investors.

Several brokerages have weighed in on MYL. Royal Bank Of Canada set a $41.00 target price on Mylan N.V. and gave the company a “hold” rating in a research note on Saturday, May 13th. Cowen and Company reaffirmed a “hold” rating and set a $30.00 target price (down previously from $43.00) on shares of Mylan N.V. in a research note on Wednesday. BMO Capital Markets reaffirmed an “outperform” rating and set a $45.00 target price (down previously from $50.00) on shares of Mylan N.V. in a research note on Thursday. UBS AG reaffirmed a “buy” rating and set a $46.00 target price (down previously from $50.00) on shares of Mylan N.V. in a research note on Thursday. Finally, Morgan Stanley cut their target price on Mylan N.V. from $52.00 to $36.00 and set an “equal weight” rating on the stock in a research note on Monday, August 7th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $47.83.

Shares of Mylan N.V. (NASDAQ:MYL) opened at 30.88 on Friday. The stock’s 50 day moving average price is $37.34 and its 200-day moving average price is $39.01. The firm has a market capitalization of $16.52 billion, a price-to-earnings ratio of 24.96 and a beta of 1.27. Mylan N.V. has a 12 month low of $29.58 and a 12 month high of $49.42.

Mylan N.V. (NASDAQ:MYL) last posted its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.18 by $0.08. The company had revenue of $2.96 billion during the quarter, compared to analyst estimates of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The business’s revenue for the quarter was up 15.7% compared to the same quarter last year. During the same period last year, the company earned $1.16 EPS. On average, equities research analysts predict that Mylan N.V. will post $4.68 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Mylan N.V. Sees Unusually Large Options Volume (NASDAQ:MYL)” was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at https://stocknewstimes.com/2017/08/12/mylan-n-v-sees-unusually-large-options-volume-nasdaqmyl.html.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply